Multicenter prospective study of peripheral arterial disease treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015926

Enrollment

5500

Registered

2014-12-12

Start date

2014-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic peripheral arterial disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Patient diagnosed as symptomatic peripheral arterial disease and scheduled for revascularization ?For retrospective data accumulation, patients been diagnosed as symptomatic peripheral arterial disease and undergone revascularization before this study

Exclusion criteria

Exclusion criteria: ?Patient who declined his/her consent

Design outcomes

Primary

Measure	Time frame
?Patency rate of the target lesion ?Rate of target lesion revascularization ?Rate of target vessel revascularization ?Rate of target limb revascularization ?Survival rate and cardio and cerebrovascular event rate	—

Secondary

Measure	Time frame
?Frequency of acute and sub-acute thrombotic occlusion after treatment ?Frequency of acute limb ischemia ?Restenosis rate of each vessel ?Patency rate for each graft material ?Changes in ankle brachial index (ABI) ?Restenosis rate of the vessel after treatment ?Incidence of acute and sub-acute occlusion of the vessel after treatment ?Additional endovascular treatment (the repeat intervention rate of the target lesion, the target vessel, and the target limb) ?Frequency of additional surgical treatment (bypass, endarterectomy) ?Frequency of major or minor amputation ?Changes in WIQ (walking impairment questionnaire) and VascQOL ?Changes in Rutherford classification ?Changes in skin perfusion pressure (SPP) ?Frequency and number of debridement (including minor amputation) ?Incidence of recurrence or de novo wound after wound heal ?Changes of leg edema after revascularization ?Change in the Visual analogue scale (VAS)	—

Measure

Time frame

?Frequency of acute and sub-acute thrombotic occlusion after treatment ?Frequency of acute limb ischemia ?Restenosis rate of each vessel ?Patency rate for each graft material ?Changes in ankle brachial index (ABI) ?Restenosis rate of the vessel after treatment ?Incidence of acute and sub-acute occlusion of the vessel after treatment ?Additional endovascular treatment (the repeat intervention rate of the target lesion, the target vessel, and the target limb) ?Frequency of additional surgical treatment (bypass, endarterectomy) ?Frequency of major or minor amputation ?Changes in WIQ (walking impairment questionnaire) and VascQOL ?Changes in Rutherford classification ?Changes in skin perfusion pressure (SPP) ?Frequency and number of debridement (including minor amputation) ?Incidence of recurrence or de novo wound after wound heal ?Changes of leg edema after revascularization ?Change in the Visual analogue scale (VAS)

—

Countries

Japan

Outcome results